Lynnette C Fallon Axcelis Technologies Inc (ACLS) insider trading activity

Lynnette C Fallon is EXECUTIVE VP, HR/LEGAL AND GEN of AXCELIS TECHNOLOGIES INC. Currently has a direct ownership of 30,406 shares of ACLS, which is worth approximately $2.32 Million. The most recent transaction as insider was on Feb 28, 2022, when has been sold 4,854 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K

0% 3M change

3.08% 12M change

Total Value Held $2.32 Million

LYNNETTE C FALLON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2022	SELL Payment of exercise price or tax liability	-	4,854 Reduced 8.66%	51,225 Common Stock
Nov 08 2021	SELL Open market or private sale	$394,107 $62.27 p/Share	6,329 Reduced 10.82%	52,151 Common Stock
Aug 27 2021	SELL Open market or private sale	$316,226 $50.58 p/Share	6,252 Reduced 9.66%	58,480 Common Stock
Aug 09 2021	SELL Open market or private sale	$219,032 $44.0 p/Share	4,978 Reduced 7.14%	64,732 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$37,053 $38.16 p/Share	971 Reduced 1.77%	53,996 Common Stock
May 17 2021	BUY Grant, award, or other acquisition	-	15,714 Added 18.4%	69,710 Common Stock
May 16 2021	SELL Payment of exercise price or tax liability	$32,131 $38.16 p/Share	842 Reduced 1.51%	54,967 Common Stock
May 15 2021	SELL Payment of exercise price or tax liability	$94,332 $38.16 p/Share	2,472 Reduced 4.24%	55,809 Common Stock
Mar 11 2021	SELL Open market or private sale	$413,474 $39.27 p/Share	10,529 Reduced 15.3%	58,281 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	-	4,496 Reduced 6.13%	68,810 Common Stock
Dec 01 2020	SELL Open market or private sale	$507,455 $27.43 p/Share	18,500 Reduced 20.15%	73,307 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$222,740 $12.04 p/Share	18,500 Added 16.77%	91,807 Common Stock
Nov 17 2020	SELL Open market or private sale	$744,848 $26.0 p/Share	28,648 Reduced 28.12%	73,220 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$228,760 $12.04 p/Share	19,000 Added 15.71%	101,968 Common Stock

Also insider at

CLPT

ClearPoint Neuro, Inc. Healthcare

Director

LCF